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stratification in critically ill patients – a
systematic review and meta-analysis
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Abstract
Background: Lactate concentration is a robust predictor of mortality but in many low resource settings facilities
for its analysis are not available. Anion gap (AG), calculated from clinical chemistry results, is a marker of metabolic
acidosis and may be more easily obtained in such settings. In this systematic review and meta-analysis we
investigated whether the AG predicts mortality in adult patients admitted to critical care settings.
Methods: We searched Medline, Embase, Web of Science, Scopus, The Cochrane Library and regional electronic
databases from inception until May 2016. Studies conducted in any clinical setting that related AG to in-hospital
mortality, in-intensive care unit mortality, 31-day mortality or comparable outcome measures were eligible for
inclusion. Methodological quality of included studies was assessed using the Quality in Prognostic Studies tool.
Descriptive meta-analysis was performed and the I2 test was used to quantify heterogeneity. Subgroup analysis
was undertaken to identify potential sources of heterogeneity between studies.
Results: Nineteen studies reporting findings in 12,497 patients were included. Overall, quality of studies was poor and
most studies were rated as being at moderate or high risk of attrition bias and confounding. There was substantial diversity
between studies with regards to clinical setting, age and mortality rates of patient cohorts. High statistical heterogeneity
was found in the meta-analyses of area under the ROC curve (I2 = 99 %) and mean difference (I2 = 97 %) for the observed
AG. Three studies reported good discriminatory power of the AG to predict mortality and were responsible for a large
proportion of statistical heterogeneity. The remaining 16 studies reported poor to moderate ability of the AG to predict
mortality. Subgroup analysis suggested that intravenous fluids affect the ability of the AG to predict mortality.
Conclusion: Based on the limited quality of available evidence, a single AG measurement cannot be recommended for
risk stratification in critically ill patients. The probable influence of intravenous fluids on AG levels renders the AG an
impractical tool in clinical practice. Future research should focus on increasing the availability of lactate monitoring in low
resource settings.
PROSPERO registration number: CRD42015015249. Registered on 4th February 2015.
Abbreviations: AG, Anion gap; APACHE II, Acute physiology and chronic health evaluation ii; AUC, Area under the ROC
curve; AVPU, Alert, verbal, pain, unresponsive; CIs, Confidence intervals; DKA, Diabetic ketoacidosis; ENT, Ear nose and throat;
GCS, Glasgow coma scale; ICCU, Intensive cardiac care unit; ICU, Intensive care unit; IQR, Interquartile range; ISS, Injury
severity score; Mdn, Median; MI, Myocardial infarction; OR, Odds ratio; PCI, Percutaneous coronary intervention;
PRISMA, Preferred reporting items for systematic reviews and
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Background
Much research has focussed on the prognostic value of
serum lactate estimation in critically ill patients [1];
however, in the context of work in low resource set-
tings we have noted that facilities for lactate and blood
gas analysis are frequently not available, prompting a
search for alternative risk stratification tools. The anion
gap (AG) is an easily calculated marker of metabolic
acidosis based on analytes typically available from
routine chemistry analysis. It may have potential as a
risk stratification tool to identify sick patients at risk of
deterioration, who would benefit from further manage-
ment whilst pathophysiological processes are still
reversible. The AG reflects the concentration of
unmeasured anions as calculated by the formula Na+ -
(Cl− + HCO3
−). Inclusion of potassium in the formula is
recommended where its concentration is abnormally
high or low [2]. In healthy subjects, the unmeasured
anions or “gap” is mostly made up of albumin; however,
hypoalbuminaemia, commonly observed in critically
ill patients, can lower the AG and mask an acidosis.
Feldman and colleagues therefore recommended that
the AG should be corrected for albumin [3].
In metabolic acidosis, addition of fixed acids leads to a
rise of the AG: while the proton within the acid combines
with bicarbonate, the conjugate base contributes to the
unmeasured anions. Metabolic acidosis is common in
critically ill patients and is a strong predictor of prognosis
[4]. Maciel and Park observed that unmeasured anions
accounted for the majority of metabolic acidosis in both
intensive care unit (ICU) survivors and non-survivors,
whereas lactate accounted for only a quarter of acidosis
[5]. AG may thus have potential as a risk stratification
tool, especially if corrected for albumin.
The validity of the AG as a predictor of mortality has
been studied and has been compared to other indices of
acid–base balance, especially Stewart’s strong ion gap
[6]. However, the strong ion gap is more cumbersome
and expensive to measure than the AG and is thus less
suitable as a risk stratification tool in low resource
settings. In studies with contrasting findings, AG was
noted to be a very strong predictor of mortality [7] or
of limited value with neither the AG nor the strong ion
gap effective as predictors of in-hospital mortality [8].
Furthermore, it has been noted that studies conducted
in countries where gelatin-based intravenous fluids are
routinely used, such as the UK and Australia, failed to
show an association between the strong ion gap and
mortality whereas studies conducted in settings where
such fluids are not routinely used, especially the USA
were able to demonstrate an association [9, 10]. Gela-
tins are an exogenous source of unmeasured anions
[11] and an increase in AG after gelatin infusion has
been demonstrated in animal experimental studies [12].
Recently, a large study of 18,985 patients found that
ΔAG, defined as the difference in AG between pre-
hospital admission and critical care admission, was a
robust predictor of all-cause mortality, where the
pre-hospital AG was determined between seven and
365 days before admission [13]. However, this approach
requires adequate documentation and a laboratory
database, which are unlikely to be available in
resource-limited settings.
In the present systematic review and meta-analysis we
therefore aimed to determine the validity of a single AG
measurement as a risk stratification tool predicting 31-
day mortality in-hospital mortality, in-ICU mortality and
comparable outcome measures in adult patients admit-
ted to critical care settings. We also aimed to compare
the prognostic validity of the observed and albumin-
corrected AG. Although the AG as a risk stratification
tool would be mainly applicable to low income coun-
tries, this systematic review and meta-analysis does not
limit itself to studies conducted in such countries as the
main focus lies on the scientific validity of the AG as a
risk stratification tool.
Methods
Protocol registration
This systematic review and meta-analysis adheres to the
“preferred reporting items for systematic reviews and
meta-analyses” (PRISMA) standards [14]. A protocol
was registered with PROSPERO, registration number
CRD42015015249.
Search strategy, study selection and data extraction
We searched the electronic databases of Medline,
Embase, Scopus, Medion, The Cochrane Library, Web
of Science and regional bibliographic databases includ-
ing African Index Medicus, Latin America and the
Caribbean (LILACS), IndMed, Index Medicus for South
East Asia Region (IMSEAR) and Western Pacific
Region Index Medicus (WPRIM). In addition, journals
specialising in the fields of critical care, anaesthetics,
emergency medicine and intensive care medicine were
searched electronically. Searches were performed for
studies that were conducted on humans and published
in English, German or French using the search terms
“anion gap”, “unmeasured anions” and “unidentified
acids”. The initial search was performed in January
2015 and the search was subsequently updated in May
2016. All search results were initially screened by
abstract and title and those considered relevant subse-
quently underwent full-text screening. To identify fur-
ther relevant studies, reference lists were reviewed,
citation searches were performed and citation alerts
were set up for all articles considered relevant after
full-text screening.
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Studies, conducted in any acute care clinical setting,
were eligible for inclusion if they were published
within the last 15 years, reported measurement of the
observed and/or corrected serum AG in adult patients
and mortality defined as “in-hospital mortality”, “in
ICU mortality” or, if a time-frame was stated, death
within up to 31-days of hospital admission. The latter
definition was chosen where both outcomes were
reported within a single study. Case studies, case–
control studies and studies whose main focus was a
hyperglycaemic emergency, poisoning or renal failure
were excluded.
Data extraction was performed by a single reviewer, SG.
A second reviewer, WS, independently extracted data
from 10 % of the studies selected using a random number
generator. Corresponding authors were contacted where
necessary to discuss missing or unclear data.
Assessment of methodological quality and risk of bias
Two reviewers (SG and WS) independently graded the
methodological quality and risk of bias of included stud-
ies using a modified version of the Quality In Prognostic
Studies (QUIPS) tool [15]. This tool assesses the risk of
bias of prognostic studies in six domains: study partici-
pation, study attrition, prognostic factor measurement,
outcome measurement, confounding, and statistical
analysis and reporting. Each study was rated as being at
high, moderate or low risk of bias in each domain.
Disagreements were resolved by discussion between the
two reviewers.
Statistical analysis
Area under the ROC curve (AUCs), odds ratios (ORs)
and mean differences were pooled in random or fixed
effects generic inverse variance models for the observed
and corrected AG. The I2 test was used to quantify hetero-
geneity. A fixed-effects model was used where the I2 was
below 30 %; otherwise, a random-effects model was used.
Meta-analysis of ORs and mean differences was under-
taken in Review Manager version 5.3 (The Cochrane Col-
laboration, 2014, Copenhagen), while AUCs were pooled
in StatsDirect version 2.8.0 (England: StatsDirect Ltd.
2013); an AUC of ≥0.8 was considered to denote good dis-
criminatory power. Pooled estimates were not presented
in forest plots due to high heterogeneity in the meta-
analyses of AUC and mean difference; in the results sec-
tion the pooled estimates are reported together with their
respective 95 % confidence intervals (CIs). Subgroup ana-
lysis was undertaken to assess whether heterogeneity be-
tween studies could be explained by the following study
characteristics: patient age, study setting, quantity of intra-
venous fluids received, determination of the AG before
the initiation of hospital-based treatment, the routine use
of gelatin-based intravenous fluids in the study country,
choice of outcome measure, publication date and overall
mortality.
Statistical significance testing for subgroup differ-
ences employed the unpaired t-test in GraphPad®
QuickCalc Web Calculator (La Jolla California USA)
[16]. Probabilities were two-tailed and a probability of
less than 0.05 was considered statistically significant.
No adjustments were made for multiple comparisons.
Sensitivity analysis was undertaken to assess the effect
of including retrospective studies and studies at high
risk of attrition bias in the meta-analysis. Funnel plots
were visually inspected for evidence of publication bias.
Results
Study selection and characteristics of included studies
The study selection process is summarised in Fig. 1. In
total, the search yielded 2688 non-duplicate publications;
2630 articles were excluded after title and abstract
screening thus 58 articles were retrieved in full-text.
Twenty-nine articles were excluded during full-text
screening, leaving 29 studies that were subjected to data
extraction. Ten studies were excluded during data ex-
traction and thus 19 studies were included in the sys-
tematic review, of which 18 were included in one or
more quantitative syntheses.
Table 1 illustrates the characteristics of included
studies. A majority of studies were conducted in high
income countries [7, 8, 16–26] while three studies were
conducted in middle income countries [27–29] and
one in a low income country [30]. Studies were con-
ducted in the following settings: ICU (10 studies),
trauma centre (5 studies), coronary care unit/intensive
cardiac care unit (3 studies) and Accident and Emer-
gency department (1 study). Five studies accounted for
the effect of intravenous fluids on AG levels: in one
study no patient received more than 400 ml of any
intravenous fluid before the AG was measured [7], in
two studies patients receiving more than 250 ml or
500 ml of intravenous fluids respectively were excluded
from the analysis [16, 30]. Two studies stated that the
AG was determined before hospital based manage-
ment, including intravenous fluids, was initiated [21,
29]. The remaining studies did not report on the quan-
tity of intravenous fluids received by their study
cohorts. No study reported both in-hospital and a
time-frame specific mortality. One study [29] failed to
define the outcome measure, reporting it as “mortal-
ity”. Sensitivity analysis was carried out to determine
whether inclusion of this study affected the pooled
effect measure. The risks of bias ratings are displayed
in Table 2. Risk of attrition bias and confounding were
the most poorly rated domains. There were no dis-
agreements between review authors on data extraction.
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Fig. 1 Flow chart summarising the search and study selection process. DKA = diabetic ketoacidosis; SOFA = sequential organ failure assessment score
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Table 1 Characteristics of included studies
First author/year Nr Country Setting and most frequent
reasons for admission
Study
design
Age (mean or
mdn)
Sample
size
Male
(%)
Outcome
(mortality)
Total mortality
(%)
Severity of illness (mean
score ± SD or mdn and
range or IQR)
Antonini 2008 [17] 1 Italy General ICU admissions: 36 %
trauma; 26 % cerebrovascular
disease; 14 % sepsis
Pro Mean: 53 136 71 28-day 27 SOFA: 6 (range 0–18)
SAPS II: 40 (range 6–76)
Attanà 2013 [18] 2 Italy STEMI patients with persistent
cardiogenic shock after primary
PCI admitted to ICCU
Pro Mean: 73 63 62 In-ICCU 49 APACHE II: 20.6 ± 12.4
Boniatti 2011 [27] 3 Brazil General ICU admissions: 64 %
medical admissions; 27 % sepsis;
24 % elective surgery; 12 %
emergency surgery
Pro Mean: 56 175 53 In-hospital 37 APACHE II: 20.8 ± 8.0
SOFA score: 6.2 ± 3.8
Cusack 2002 [19] 4 UK General ICU admissions: 17 %
respiratory failure; 11 % post-
cardiac arrest; 8 % trauma
Pro Mean: 61 100 NA 28-day 31 APACHE II: 20.5
Dondorp 2004 [29] 5 Vietnam Patients with severe falciparum
malaria admitted to ICU
Pro Mdn: 31 268 80 Not defined 17 GCS < 11: 51 %
8 % Haemodynamic shocka
Dubin 2007 [37] 6 Argentina General ICU admissions: 56 %
medical admissions; 35 %
elective surgery; 9 %
emergency surgery
Pro Mean: 65 935 49 30-day 11 APACHE II: 13 ± 7
SOFA: 3 ± 3
FitzSullivan 2005 [20] 7 USA Trauma ICU admissions:
60 % blunt trauma
Retro Mean: 36 3102 81 In-hospital 17 APACHE II: 26.1 ± 10.5
ISS: 20.4 ± 12.9
Hucker 2005 [21] 8 UK A&E admissions: 46 % medical
admissions; 17 % elderly care;
16 % discharged
Pro Mean: 67 672 NA In-hospital 12 93 % alert on AVPU scale
Kaplan 2004 [7] 9 USA Trauma patients requiring
vascular repair of torso or
extremities, trauma centre:
83 % penetrating trauma
Retro Mean: 32 282 NA 28-day 23 ISS: 15.8 ± 11.0
Kaplan 2008 [16] 10 USA Major trauma patients, trauma
centre: 59 % blunt trauma
Retro Mean: 33 78 44 28-day in
hospital
33 ISS: 8.9 ± 7.3
Lazzeri 2010 [22] 11 Italy STEMI patients admitted to ICCU
at tertiary centre undergoing
primary PCI
Pro Mdn: 67 445 75 In-hospital 10 92 % Killip class I-II
8 % Killip class II-IV
41 % complications in ICCU
Lipnick 2013 [13] 12 USA General ICU admissions: 57 %
medical; 44 % surgical; 16 %
sepsis
Retro Mean: 65 664 55 30-day 15 33 % no organ failure
53 % 1–2 organs failed
14 %%≥ 3 organs failedb
Martin 2013 [23] 13 Germany Surgical ICU admissions: 17 %
maxillofacial surgery; 13 % ENT;
12 % neurosurgery
Retro Mean: 59 1551 54 In-hospital 9 Average length of stay in ICU:
4.2 days
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Table 1 Characteristics of included studies (Continued)
Martin 2005a [25] 14 USA Surgical ICU admissions: 56 %
abdominal; 18 % vascular; 10 %
thoracic
Retro Mean: 52 2291 61 In-ICU 8 APACHE II: 21.8 ± 9.7
SAPS: 16.8 ± 8.8
Martin 2005b [24] 15 USA Trauma patients, trauma centre:
65 % blunt
trauma
Retro Mean: 38 427 79 In-hospital 10 ISS: 23 ± 23
Novovic 2014 [28] 16 Serbia ICU patients requiring
mechanical ventilation
Retro Mean: 60 142 47 28-day 52 APACHE II: 16.2 ± 6.4
Rocktaeschel 2003 [8] 17 Australia General ICU admissions: 91 %
respiratory; 54 % gastrointestinal;
51 % cardiovascular
Retro Mdn: 65 300 58 In-hospital 28 APACHE II: 17 (IQR 14 – 22)
Sahu 2006 [26] 18 USA Patients with acute MI admitted
to coronary care unit: 65 % STEMI
Retro Mean: 63 773 62 In-hospital 11 5 % cardiogenic shock
Shane 2014 [30] 19 Uganda Major trauma patients, trauma
centre: 65 % road traffic
accidents; 35 % assault
Pro Mean: 26 93 81 In-hospital 34 ISS: 25.4 ± 8.3
APACHE II Acute Physiology and Chronic Health Evaluation, AVPU alert, verbal, pain, unresponsive, ENT ear, nose and throat, GCS Glasgow coma scale, ICCU intensive cardiac care unit, ICU intensive care unit, IQR
interquartile range, ISS Injury Severity Score, Mdn median, MI myocardial infarction, PCI percutaneous coronary intervention, Pro prospective, Retro retrospective, SAPS simplified acute physiology score, SD standard
deviation, SOFA sequential organ failure assessment, STEMI ST-elevation myocardial infarction
aBased on data of previously published original study including 346 patients [38]
bBased on data from entire study cohort of 18,995 patients
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Prognostic ability of the AG to predict mortality
Owing to the high heterogeneity identified in the meta-
analyses of AUC and mean difference, the pooled effect
measures reported in this section should not be inter-
preted. Overall, three studies reported good discrimin-
atory ability of the AG to predict mortality, of which two
studies were included in meta-analysis [7, 16] and one
study allowed the calculation of an OR for a specific AG
threshold [22]. The former two studies were responsible
for a large proportion of the statistical heterogeneity;
both studies were conducted in young patients in the
same trauma centre and only patients receiving less than
a specified volume of intravenous fluids were included
in the analysis. The latter study was conducted in
patients with ST-elevation myocardial infarction undergo-
ing percutaneous coronary intervention. The remaining
16 studies reported poor to moderate ability of the AG to
predict mortality.
Table 2 Risk of bias rating
Green, Yellow and Red refer to low, moderate and high risk of bias respectively
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Nine studies reported AUCs for the observed AG
(Fig. 2). Meta-analysis yielded a summary AUC of 0.72
(95 % CI 0.59 to 0.86). Heterogeneity was very high (I2 =
99 %) but reduced to I2 = 68 % when the two studies by
Kaplan and Kellum were excluded from the analysis [7,
16]. Six studies reported AUCs for the corrected AG
(Additional file 1: Figure S1). The summary AUC was
estimated as 0.67 (95 % CI 0.62 to 0.71) and heterogen-
eity was high (I2 = 67 %).
Six studies reported ORs derived by logistic regression
modelling for the observed AG (Fig. 3); five reported
univariate logistic regression ORs whilst one study
reported an OR adjusted for age. The summary OR was
1.08 (95 % CI 1.06 to 1.11); results were homogenous
(I2 = 0 %) but it should be noted that the two studies by
Kaplan and Kellum were not included in this analysis as
neither study reported the OR. Four studies reported
ORs derived by univariate logistic regression for the
corrected AG (Additional file 2: Figure S2). The sum-
mary OR was 1.10 (95 % CI 1.07 to 1.13) and heterogen-
eity was very low (I2 = 5 %). Data reported in the study
of Lazzeri and colleagues allowed the calculation of an
OR for a specified AG positivity threshold. This yielded
an OR of 2.8 (95 % CI 1.5 to 5.5) for an AG positivity
threshold of 11 mEq/L [22].
Mean difference was the most frequently reported ef-
fect measure with ten studies reporting it for the ob-
served AG (Fig. 4). The summary mean difference was
3.55 mEq/L (95 % CI 1.08 to 6.02). Heterogeneity was high
(I2 = 97 %); however, excluding the study by Kaplan and
Kellum [7] completely eliminated heterogeneity (I2 = 0 %).
The mean difference for corrected AG was reported by
three studies (Additional file 3: Figure S3) and the sum-
mary mean difference was estimated as 3.25 mEq/L (95 %
CI 1.53 to 4.96) with homogeneous results (I2 = 0 %).
Sensitivity analysis showed that including retrospective
studies and studies at risk of attrition bias did not affect
the summary AUC. Including prospective studies only
(six studies) yielded a summary AUC of 0.73 (95 % CI
0.69 to 0.78). Similarly, excluding studies rated at high
risk of attrition bias (four studies) yielded a summary
AUC of 0.75 (95 % CI 0.54 to 0.96). Excluding the study
by Dondorp and colleagues [31] with an undefined out-
come measure (“mortality”) yielded an AUC of 0.72
(95 % CI 0.56 to 0.88).
AUC of observed AG was chosen for subgroup analysis;
results are shown in Table 3. The quantity of intravenous
fluids given to a patient had the strongest influence on the
summary AUC. Studies excluding patients who received
more than a specified volume of intravenous fluids [7, 16]
reported a significantly higher summary AUC than studies
not excluding patients for this reason (P = 0.0008), but
heterogeneity remained high in both subgroups. For the
subsequent analysis, studies restricting intravenous fluids
[7, 16] and studies measuring the AG before initiation of
hospital-based management [21, 29] were combined in a
subgroup and compared to studies that did not account in
any way for the effect of intravenous fluids on the AG.
The former subgroup yielded a significantly higher sum-
mary AUC than the latter subgroup (P <0.0001). Hetero-
geneity remained high in the former subgroup (I2 = 98 %),
though results in the latter subgroup were homogenous
Fig. 2 Forest plot of area under the ROC curves (AUCs) for observed AG predicting mortality. Forest plot of a random effects meta-analysis of
AUCs for the observed AG predicting mortality; I2 = 99 %. In view of the high heterogeneity a pooled effect estimate is not shown
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(I2 = 0 %). The summary AUC of studies conducted in
countries where gelatin-based resuscitation fluids are rou-
tinely used [8, 19, 28] is not significantly different to that
of studies conducted in countries where gelatins are not
routinely used [13, 24] (P = 0.33). Studies in which intra-
venous fluids were restricted or in which the AG was mea-
sured before initiation of hospital-based treatment were
not included in the latter comparison. The observed AG
appears to be a slightly better predictor of mortality among
younger patients (P = 0.011) and those admitted to trauma
centre settings (P = 0.0235). Subgroup analysis showed no
significant difference between studies reporting in-hospital
mortality and those reporting a time-framed mortality (P
= 0.65); similarly, no significant difference was found be-
tween studies in which overall mortality was below 30 %
and above 30 % (P = 0.89) or between studies published
before and after the year 2005 (P = 0.43); and heterogeneity
remained high in all subgroups. Funnel plots did not show
evidence of publication bias (Additional file 4: Figure S4
and Additional file 5: Figure S5).
Discussion
This systematic review and meta-analysis does not support
the use of a single AG measurement for risk stratification
in critically ill patients. Quantitative synthesis was limited
by significant statistical heterogeneity, which, following a
series of subgroup analyses, could be partially explained by
the quantity of intravenous fluids received by study pa-
tients. Studies differed substantially with regards to setting,
presumed use of gelatin-based intravenous fluids as well as
the age and mortality rate of their patient cohorts; how-
ever, in our analysis none of these factors fully accounted
for the high degree of heterogeneity. Disease severity was
not consistently characterised across studies and could
therefore not be analysed in subgroup analysis. Overall,
the high degree of unexplained heterogeneity, poor quality
of primary studies and poor to moderate discriminatory
power of the AG reported by the majority of studies
suggest that there is insufficient evidence to recommend
the use of the AG in clinical practice. Owing to the small
number of studies that calculated a corrected AG, we were
unable to determine whether correction of the AG for
albumin improves its predictive ability.
In subgroup analysis, a highly statistically significant dif-
ference was seen between studies accounting for intraven-
ous fluids by means of fluid restriction or by measuring
the AG before the initiation of hospital-based manage-
ment and studies that did not account for quantity of
intravenous fluids by any means. This indicates that intra-
venous fluids may have blurred the association between
AG and mortality. Administration of normal saline lowers
the AG because addition of NaCl to the plasma increases
the baseline chloride concentration proportionately more
than the baseline sodium concentration, owing to the
Fig. 3 Forest plot of odds ratios (ORs) for observed AG predicting mortality. Forest plot of a fixed effects meta-analysis of ORs derived by
univariate logistic regression for the observed AG predicting mortality; I2 = 0 %. In view of the high heterogeneity in meta-analyses of
other effect measures a pooled effect estimate is not shown
Fig. 4 Forest plot of mean differences for observed AG predicting mortality. Forest plot of mean differences in observed AG between survivors
and non-survivors; I2 = 96 %. In view of the high heterogeneity a pooled effect estimate is not shown
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differences in volume of distribution between the two ions
[4]. This effect may not be seen with more balanced fluids
such as Hartman’s solution but, given that normal saline is
commonly used in clinical practice, a risk stratification
tool that is considerably affected by saline infusion is im-
practical. However, the validity of this subgroup analysis is
limited by its observational nature and relatively small
number of studies contained in each subgroup. Therefore,
other confounders may have accounted for these results.
Furthermore, the study by Shane and colleagues [30] also
employed intravenous fluid restriction but found no
predictive effect of the AG; however, only mean difference
in AG between survivors and non-survivors but not AUC
was reported. Further research would be required to
determine more conclusively the extent to which the AG
is affected by intravenous fluids.
Other than intravenous fluid restriction, our subgroup
analysis did not identify factors accounting for the high
statistical heterogeneity in the meta-analysis of AUC. A
small effect of study setting and mean/median age on
the pooled AUC was observed; however, the associated
probabilities were >0.01 where no adjustments were
made for multiple comparisons and in both analyses one
subgroup contained the two studies by Kaplan and
Kellum [7, 16]. Therefore, we consider the observed
differences most likely to have arisen due to chance or
confounding. Notably, no significant effect of outcome
measure or publication date was observed on the pooled
AUC. This supports the appropriateness of including
studies reporting a time-framed mortality and in-hospital
mortality and studies published at different times over the
past 15 years. As parameters denoting disease severity
were not consistently reported across studies, we divided
studies according to overall mortality in subgroup analysis.
No difference in pooled AUC was seen between studies
reporting mortality rates above and below 30 %; however,
overall mortality is a suboptimal indicator of severity of
illness. Therefore, the contribution of disease severity to
the observed statistical heterogeneity remains unclear.
Another important factor limiting the ability of the
AG to predict clinical outcomes is its considerable base-
line variability amongst healthy people. To address this,
Kraut and Nagami suggested comparing the AG during
an acute admission to the “personal AG” measured when
the individual was in good health [2]. Dynamic AG indi-
ces, describing not only the magnitude of acid–base
Table 3 Results of subgroup analysis
Study characteristic Groups Studies (nr) Total
sample size
Pooled AUC
(95 % CIs)
I2 test P-value
Study setting Trauma patients 9, 10, 15 787 0.83 (0.68, 0.99) 97 % 0.0235
ICU patients 4, 5, 12, 16, 17 1474 0.66 (0.59, 0.73) 69 %
Age Mean/Median age
30–40 years
5, 9, 10, 15 1055 0.81 (0.69, 0.93) 97 % 0.0114
Mean/Median age
60–70 years
4, 8, 12, 16, 17 1878 0.66 (0.60, 0.71) 70 %
Intravenous
fluids restriction
Restriction 9, 10 356 0.91 (0.8, 1.0) 95 % 0.0008
No restriction 4, 5, 8, 12, 15, 16, 17 2573 0.67 (0.62, 0.72) 68 %
Intravenous fluids
restriction and AG
measured before
treatment initiation
Restriction and AG
measurement before
hospital treatment
initiation
5, 8, 9, 10 1296 0.83 (0.73, 0.93) 98 % <0.0001
No restriction or AG
measured after
treatment was
commenced
4, 12, 15, 16, 17 1633 0.63 (0.60, 0.66) 0 %
Routine use of
gelatin-based intravenous
fluids in study country
Gelatins not routinely
used
12, 15 1091 0.62 (0.58, 0.65) 0 % 0.3344
Gelatins routinely used 4, 16, 17 542 0.65 (0.6, 0.7) 0 %
Outcome measure Time frame stated e.g.
31-day or 28-day mortality
4, 9, 10, 12, 16 1266 0.74 (0.52, 0.96) 99 % 0.6518
In-hospital mortality 8, 15, 17 1399 0.69 (0.64, 0.75) 44 %
Overall mortality in
study population
Below 30 % 5, 8, 9, 12, 15, 17 2613 0.74 (0.55, 0.93) 99 % 0.8856
Above 30 % 4, 10, 16 320 0.70 (0.57, 0.84) 83 %
Date of publication Before and including 2005 4, 5, 8, 9, 15 1710 0.76 (0.59, 0.94) 98 % 0.4325
2006 and after 10, 12, 16, 17 1184 0.67 (0.58, 0.77) 87 %
CIs confidence intervals, ICU intensive care unit
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disturbance but also trends over time, are better predic-
tors of mortality, as shown by the large study by Lipnick
and colleagues including 18,995 patients [13]. For a sub-
set of patients in this study (n = 664), the predictive abil-
ity of a single AG measurement was also reported and
was shown to be poor (AUC 0.61). However, implemen-
tation of the systems required to support a “personal
AG” would be challenging in low resource settings.
A rise in the AG in critically ill patients was long
thought to be predominantly due to lactic acidosis, yet
several studies reported poor sensitivity of the AG in de-
tecting hyperlactataemia defined by a lactate threshold
of 2.5 mmol/l [31–34]. The AG was an excellent pre-
dictor of severe hyperlactataemia defined as lactate
above 4 mmol/l [32] or 5 mmol/l [8]; however, Nichol
and colleagues found that a higher lactate concentration
even within a normal reference range of 2 mmol/l inde-
pendently predicts mortality [35]. The AG may thus
miss patients at risk of mortality, as a considerable
degree of hyperlactataemia is required to push the AG
outside its normal reference range if the baseline AG is
low [2]. This is in keeping with the extreme difference in
lactate levels between survivors and non-survivors ob-
served in the study reporting the highest predictive value
of AG [7]. Other studies reported smaller, albeit mostly
statistically significant, differences in lactate levels be-
tween survivors and non-survivors.
Limitations
The methodological quality of primary studies was
generally poor. Most studies were rated at moderate or
high risk of attrition bias and sampling bias as a result of
failure to quantify missing outcome or prognostic data,
especially in retrospective studies, where case notes with
missing information are less likely to have been available.
This may have affected our results where information
was missing in a non-random manner. Similarly, risk of
confounding was moderate to high in the majority of
studies. Only one study explored the influence of age on
AG levels, and stratification was not employed by any
study; the risk of confounding affecting the review out-
come is therefore high. Several studies did not report
relevant effect measures, such as OR, AUC or mean
difference or failed to provide confidence intervals, lead-
ing to exclusion from this review. Furthermore, the over-
all severity of illness in the study cohort was sometimes
not quantified by means of an accepted disease severity
score, such as the Acute Physiology and Chronic Health
Evaluation II (APACHE II), Sequential Organ Failure
Assessment (SOFA) score or Injury Severity Score (ISS)
in trauma patients. No studies reported short-term mor-
tality outcomes, which may have been more appropriate
as naturally the prognosis in critical care patients is
heavily influenced by clinical interventions undertaken
during the inpatient stay. Shapiro and colleagues found
that a single lactate level drawn on admission has good
discriminatory power to predict 3-day mortality (AUC =
0.8) but poor discriminatory power to predict 28-day
mortality (AUC = 0.67) [36]. Lastly, few studies stated
the types of intravenous fluids used and no study in-
cluded the quantity of intravenous fluid used as a vari-
able in multivariate analysis.
Conclusion
The high degree of unexplained statistical heterogeneity,
considerable diversity between patient cohorts and poor
quality of primary studies, in particular the high risk of
attrition bias and confounding, impact on the overall
strength of evidence of this systematic review and meta-
analysis. The majority of studies reported here do not
support the use of the AG as a predictor of 31-day mor-
tality, in-ICU mortality or in-hospital mortality. There-
fore, based on the available evidence, the use of a single
AG measurement for risk stratification in critically ill
patients cannot be recommended. Further high quality
research would be required to conclusively determine
the validity of the AG as a predictor of mortality. How-
ever, the probable influence of intravenous fluids on AG
levels and the substantial baseline variability between
AG levels among healthy individuals may render the use
of the AG problematic in clinical practice. In light of the
growing body of evidence supporting the use of lactate
concentration for monitoring of critically ill patients, it
may be more worthwhile to focus efforts on increasing
the capacity for lactate measurement in low resource
settings.
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